ArticleProceedings of the National Academy of Sciences of the United States of America2025

Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates.

Xuefei Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.